Asian market advanced on Thursday, 30 April 2020, on following U.S. shares advancing overnight on reports the antiviral drug remdesivir is showing promise as an effective COVID-19 treatment.
Gilead Sciences said on Wednesday that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks. Later Wednesday, White House health advisor Dr. Anthony Fauci said NIAID's remdesivir drug trial, which enrolled about 800 patients, showed quite good news and that the drug would set a new standard of care for Covid-19 patients.
Globally, the coronavirus pandemic has infected more than 3.1 million and taken at least 226,771 lives, according to data compiled by John Hopkins University.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
